Evidence-Based Guidelines Should Be Used To Inform COVID-19 Management.
Publication
, Journal Article
Holland, TL
Published in: Antimicrob Agents Chemother
February 17, 2021
Duke Scholars
Published In
Antimicrob Agents Chemother
DOI
EISSN
1098-6596
Publication Date
February 17, 2021
Volume
65
Issue
3
Location
United States
Related Subject Headings
- SARS-CoV-2
- Pyrazines
- Microbiology
- Humans
- COVID-19
- Amides
- 3214 Pharmacology and pharmaceutical sciences
- 3207 Medical microbiology
- 3107 Microbiology
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Holland, T. L. (2021). Evidence-Based Guidelines Should Be Used To Inform COVID-19 Management. Antimicrob Agents Chemother, 65(3). https://doi.org/10.1128/AAC.02501-20
Holland, Thomas L. “Evidence-Based Guidelines Should Be Used To Inform COVID-19 Management.” Antimicrob Agents Chemother 65, no. 3 (February 17, 2021). https://doi.org/10.1128/AAC.02501-20.
Holland TL. Evidence-Based Guidelines Should Be Used To Inform COVID-19 Management. Antimicrob Agents Chemother. 2021 Feb 17;65(3).
Holland, Thomas L. “Evidence-Based Guidelines Should Be Used To Inform COVID-19 Management.” Antimicrob Agents Chemother, vol. 65, no. 3, Feb. 2021. Pubmed, doi:10.1128/AAC.02501-20.
Holland TL. Evidence-Based Guidelines Should Be Used To Inform COVID-19 Management. Antimicrob Agents Chemother. 2021 Feb 17;65(3).
Published In
Antimicrob Agents Chemother
DOI
EISSN
1098-6596
Publication Date
February 17, 2021
Volume
65
Issue
3
Location
United States
Related Subject Headings
- SARS-CoV-2
- Pyrazines
- Microbiology
- Humans
- COVID-19
- Amides
- 3214 Pharmacology and pharmaceutical sciences
- 3207 Medical microbiology
- 3107 Microbiology
- 1115 Pharmacology and Pharmaceutical Sciences